世界の認知症・運動障害治療市場は、予測期間中に約6.95 %のCAGRで推移し、2022年から2026年の間に71億4,000万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。
本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、高齢者人口の増加、対象疾患の有病率の上昇、国民の意識を高める戦略の出現によって牽引されています。
本調査では、今後数年間における認知症・運動障害治療市場の成長を促進する主要な理由の一つとして、バイオマーカーの出現を挙げています。また、アルツハイマー病に伴う認知機能の低下を回復させるための遺伝子治療の成長と生物医学の進歩が、市場の大きな需要につながると考えられます。
TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な認知症・運動障害治療市場ベンダーの詳細な分析を提供します
この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。
TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Drug Class
5.1 Market segments
Exhibit 24: Chart on Drug Class - Market share 2021-2026 (%)
Exhibit 25: Data Table on Drug Class - Market share 2021-2026 (%)
5.2 Comparison by Drug Class
Exhibit 26: Chart on Comparison by Drug Class
Exhibit 27: Data Table on Comparison by Drug Class
5.3 MAO inhibitors - Market size and forecast 2021-2026
Exhibit 28: Chart on MAO inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on MAO inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on MAO inhibitors - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on MAO inhibitors - Year-over-year growth 2021-2026 (%)
5.4 Acetylcholinesterase inhibitors - Market size and forecast 2021-2026
Exhibit 32: Chart on Acetylcholinesterase inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Acetylcholinesterase inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Acetylcholinesterase inhibitors - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Acetylcholinesterase inhibitors - Year-over-year growth 2021-2026 (%)
5.5 Glutamate inhibitors - Market size and forecast 2021-2026
Exhibit 36: Chart on Glutamate inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Glutamate inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Glutamate inhibitors - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Glutamate inhibitors - Year-over-year growth 2021-2026 (%)
5.6 Others - Market size and forecast 2021-2026
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Drug Class
Exhibit 44: Market opportunity by Drug Class ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 France - Market size and forecast 2021-2026
Exhibit 82: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on France - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 AbbVie Inc.
Exhibit 93: AbbVie Inc. - Overview
Exhibit 94: AbbVie Inc. - Product / Service
Exhibit 95: AbbVie Inc. - Key offerings
10.4 Biogen Inc.
Exhibit 96: Biogen Inc. - Overview
Exhibit 97: Biogen Inc. - Product / Service
Exhibit 98: Biogen Inc. - Key offerings
10.5 Eisai Co. Ltd.
Exhibit 99: Eisai Co. Ltd. - Overview
Exhibit 100: Eisai Co. Ltd. - Business segments
Exhibit 101: Eisai Co. Ltd. - Key offerings
Exhibit 102: Eisai Co. Ltd. - Segment focus
10.6 H Lundbeck AS
Exhibit 103: H Lundbeck AS - Overview
Exhibit 104: H Lundbeck AS - Product / Service
Exhibit 105: H Lundbeck AS - Key offerings
10.7 Johnson and Johnson
Exhibit 106: Johnson and Johnson - Overview
Exhibit 107: Johnson and Johnson - Business segments
Exhibit 108: Johnson and Johnson - Key news
Exhibit 109: Johnson and Johnson - Key offerings
Exhibit 110: Johnson and Johnson - Segment focus
10.8 Merck and Co. Inc.
Exhibit 111: Merck and Co. Inc. - Overview
Exhibit 112: Merck and Co. Inc. - Business segments
Exhibit 113: Merck and Co. Inc. - Key news
Exhibit 114: Merck and Co. Inc. - Key offerings
Exhibit 115: Merck and Co. Inc. - Segment focus
10.9 Novartis AG
Exhibit 116: Novartis AG - Overview
Exhibit 117: Novartis AG - Business segments
Exhibit 118: Novartis AG - Key offerings
Exhibit 119: Novartis AG - Segment focus
10.10 Otsuka Holdings Co. Ltd.
Exhibit 120: Otsuka Holdings Co. Ltd. - Overview
Exhibit 121: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 122: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 123: Otsuka Holdings Co. Ltd. - Segment focus
10.11 Teva Pharmaceutical Industries Ltd.
Exhibit 124: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 125: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 126: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 127: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 128: Teva Pharmaceutical Industries Ltd. - Segment focus
10.12 UCB SA
Exhibit 129: UCB SA - Overview
Exhibit 130: UCB SA - Product / Service
Exhibit 131: UCB SA - Key offerings
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 132: Inclusions checklist
Exhibit 133: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 134: Currency conversion rates for US$
11.4 Research methodology
Exhibit 135: Research methodology
Exhibit 136: Validation techniques employed for market sizing
Exhibit 137: Information sources
11.5 List of abbreviations
Exhibit 138: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Drug Class - Market share 2021-2026 (%)
Exhibits25: Data Table on Drug Class - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Drug Class
Exhibits27: Data Table on Comparison by Drug Class
Exhibits28: Chart on MAO inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on MAO inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on MAO inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on MAO inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Acetylcholinesterase inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Acetylcholinesterase inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Acetylcholinesterase inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Acetylcholinesterase inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Glutamate inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Glutamate inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Glutamate inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Glutamate inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Drug Class ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: AbbVie Inc. - Overview
Exhibits94: AbbVie Inc. - Product / Service
Exhibits95: AbbVie Inc. - Key offerings
Exhibits96: Biogen Inc. - Overview
Exhibits97: Biogen Inc. - Product / Service
Exhibits98: Biogen Inc. - Key offerings
Exhibits99: Eisai Co. Ltd. - Overview
Exhibits100: Eisai Co. Ltd. - Business segments
Exhibits101: Eisai Co. Ltd. - Key offerings
Exhibits102: Eisai Co. Ltd. - Segment focus
Exhibits103: H Lundbeck AS - Overview
Exhibits104: H Lundbeck AS - Product / Service
Exhibits105: H Lundbeck AS - Key offerings
Exhibits106: Johnson and Johnson - Overview
Exhibits107: Johnson and Johnson - Business segments
Exhibits108: Johnson and Johnson - Key news
Exhibits109: Johnson and Johnson - Key offerings
Exhibits110: Johnson and Johnson - Segment focus
Exhibits111: Merck and Co. Inc. - Overview
Exhibits112: Merck and Co. Inc. - Business segments
Exhibits113: Merck and Co. Inc. - Key news
Exhibits114: Merck and Co. Inc. - Key offerings
Exhibits115: Merck and Co. Inc. - Segment focus
Exhibits116: Novartis AG - Overview
Exhibits117: Novartis AG - Business segments
Exhibits118: Novartis AG - Key offerings
Exhibits119: Novartis AG - Segment focus
Exhibits120: Otsuka Holdings Co. Ltd. - Overview
Exhibits121: Otsuka Holdings Co. Ltd. - Business segments
Exhibits122: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits123: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits124: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits125: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits126: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits127: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits128: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits129: UCB SA - Overview
Exhibits130: UCB SA - Product / Service
Exhibits131: UCB SA - Key offerings
Exhibits132: Inclusions checklist
Exhibits133: Exclusions checklist
Exhibits134: Currency conversion rates for US$
Exhibits135: Research methodology
Exhibits136: Validation techniques employed for market sizing
Exhibits137: Information sources
Exhibits138: List of abbreviations
